Chlortheophylline: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Chlortheophylline. Educational only — not medical advice.

Labeled uses

Dimenhydrinate Injection, USP is indicated for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness.

Source: FDA labeling via NIH DailyMed (set bc71539e…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.